Global Interdependence Center

AIM ImmunoTech to Participate in a Solve M.E. Signature Event: ‘Long COVID: Research, Policy, and Economic Impact’ on May 19, 2022

Retrieved on: 
Thursday, May 12, 2022
Cancer, Rintatolimod, Global Interdependence Center, Company, Disease, Solve ME/CFS Initiative, Private Securities Litigation Reform Act, ME/CFS, Research, American, Science, Patient, COVID-19, PSLRA, Solve, Partnership, Lists of diseases, Awareness, AIM, Government, EAP, RNA, Myalgia, Degenerative disease, Therapy, Immune system, COVID, NYSE, GLOBE, Pharmaceutical industry, Vaccine, Long COVID, Policy

Diagnostics signature event Long COVID: Research, Policy, and Economic Impact , being held virtually and in New York, N.Y. on Thursday, May 19, 2022.

Key Points: 
  • Diagnostics signature event Long COVID: Research, Policy, and Economic Impact , being held virtually and in New York, N.Y. on Thursday, May 19, 2022.
  • The Global Interdependence Center, in partnership with the Solve Long Covid Initiative, is continuing its conference series exploring the pandemics long-term healthcare, policy, and economic impact, specifically the implications of long haul COVID (a.k.a.
  • The event is aimed at raising awareness of Long Covid by examining the science and research behind it.
  • Among other things, for those statements, the Company claims the protection of safe harbor for forward-looking statements contained in the PSLRA.

The Global Interdependence Center Features Eric Lichtenheld Among Other Business Leaders on Mexico and US Foreign Insights

Retrieved on: 
Thursday, March 12, 2020
Articles, Natural environment, Nature, Sustainable design, Conferences, Environmental design, Industrial ecology, Regenerative design, Systems theory, Regenerative agriculture, Global Interdependence Center, Regeneration

GILBERT, Ariz., March 12, 2020 /PRNewswire/ --With global climate change and challenges as a backdrop, Heliae Development, LLC, President and CEO, Eric Lichtenheld spoke at The Global Interdependence Center (GIC) during their delegation to Mexico City.

Key Points: 
  • GILBERT, Ariz., March 12, 2020 /PRNewswire/ --With global climate change and challenges as a backdrop, Heliae Development, LLC, President and CEO, Eric Lichtenheld spoke at The Global Interdependence Center (GIC) during their delegation to Mexico City.
  • Lichtenheld spoke on the immediate threats facing the future of agriculture in a joint session with Jorge Fenyvesi, CEO of Nature Source Improved Plants .
  • Lichtenheld brought his expertise from guiding Heliae in the development of cutting-edge technologies in microalgae for regenerative agriculture practices.
  • For more information on Heliae and how their work in regenerative agriculture is creating sustainable impact now, visit Heliae.com .